Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

271
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
271
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

293
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
293

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multicenter Interlaboratory Study of Thrombin Generation Assay in Healthy Adults Using the ST Genesia Analyzer With the STG-ThromboScreen Reagent (With and Without Thrombomodulin).

International journal of laboratory hematology·2026
Same author

Procoagulant Effect of FIX Concentrates and Bypass Agents in Combination with Emicizumab and Impact of FVIII Inhibitors.

Biomedicines·2026
Same author

Joint Damage Prediction in Non-Severe Hemophilia A with Artificial Intelligence.

Journal of blood medicine·2026
Same author

Thrombomodulin resistance as a novel prothrombotic pathway in COVID-19.

Scientific reports·2025
Same author

Update on the Laboratory Diagnosis of Lupus Anticoagulant: Current Challenges and Clinical Involvement.

Journal of clinical medicine·2025
Same author

Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin.

PloS one·2025

Related Experiment Video

Updated: Jan 11, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.7K

Machine learning for predicting thrombotic recurrence in antiphospholipid syndrome.

Ana Marco-Rico1,2, Ihosvany Fernández-Bello1, Jorge Mateo-Sotos3

  • 1Hospital General Universitario Dr. Balmis, Department of Hematology, Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, Spain.

Research and Practice in Thrombosis and Haemostasis
|November 17, 2025
PubMed
Summary

The extreme gradient boosting (XGB) model accurately predicts recurrent thrombotic antiphospholipid syndrome (TAPS) events, outperforming other machine learning methods. Key predictors like renal impairment and age improve risk stratification for personalized TAPS treatment.

Keywords:
antiphospholipid syndromemachine learningrecurrencerisk assessmentthrombosis

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Jan 11, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.7K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Medical research
  • Machine learning applications
  • Autoimmune disorders

Background:

  • Thrombotic antiphospholipid syndrome (TAPS) presents a high risk of recurrent thromboembolic events.
  • Current anticoagulation treatments face challenges in predicting event recurrence.
  • Enhanced risk stratification is crucial for optimizing personalized TAPS management.

Purpose of the Study:

  • To evaluate the predictive performance of the extreme gradient boosting (XGB) model for recurrent thrombotic events in TAPS.
  • To compare XGB with other machine learning algorithms for TAPS risk prediction.
  • To identify key clinical and biochemical predictors of TAPS recurrence.

Main Methods:

  • Utilized demographic and clinical data for model development.
  • Assessed model performance using metrics like accuracy, specificity, precision, and AUC.
  • Compared XGB against various machine learning algorithms.

Main Results:

  • XGB demonstrated superior performance, achieving the highest accuracy and AUC.
  • Identified renal impairment, age, and lupus anticoagulant as significant predictors.
  • XGB showed robust predictive capabilities for TAPS recurrence.

Conclusions:

  • XGB shows significant potential for improving risk stratification in TAPS.
  • The model can aid clinical decision-making and optimize anticoagulation strategies.
  • Further validation in larger, prospective studies is recommended for clinical integration.